October 22, 2020
Searching for outbreaks. The long and sometimes muddled tradition of predicting outbreak hot spots by analyzing search engine activity has continued into the COVID-19 era, with Mayo Clinic researchers publishing new findings that suggest strong correlations between certain keywords and case reports. In reviewing data from Jan. 22 to April 6, "face mask," "Lysol" and "COVID stimulus check" had the...
May 21, 2019
Cala Health, a wearable neuromodulation therapy startup focused on chronic diseases, has closed a $50 million Series C financing round.
Novartis, Baird Capital, LifeSci Venture Partners, TriVentures and other unnamed backers participated, as did returning investors JJDC, Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital and GV.
WHAT THEY DO
March 18, 2019
Cala Health, a wearable neuromodulation therapy startup with Stanford University roots, has signed a licensing deal with Partners Healthcare affiliate Massachusetts General Hospital that will provide the former with a new nerve stimulation platform for chronic disease treatments.
According to the announcement, the technologies Cala is interested in were the product of MGH research on...
March 3, 2016
So far this year, the digital health funding that MobiHealthNews tracked has surpassed $600 million. In January, digital health companies raised $471 million across 21 deals. This month, funding reached $197 million across 13 deals, although one of those deals was for an undisclosed amount.
More than half of February's funding came from one big deal: MindMaze raised $100 million. An honorary...
February 18, 2016
Cala Health, a stealthy startup out of Stanford University has raised $18 million according to an SEC filing. MedCityNews first spotted the story. Johnson & Johnson Development Corporation, Lux Capital and Lightstone Ventures all contributed to the round.
Cala Health hasn't sought much press and declined to comment to MobiHealthNews. But the SEC document reveals that the company was...